- Home
- DOO vs PTGX Comparison
DOO vs PTGX Comparison
Compare DOO & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$65.96
HOLD
Current Price
$98.51
Company Overview
Basic Information| Metric | DOO | PTGX |
|---|---|---|
| Founded | 1937 | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.2B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | DOO | PTGX |
|---|---|---|
| Price | $65.96 | $98.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 12 |
| Target Price | $75.00 | ★ $106.67 |
| AVG Volume (30 Days) | 204.0K | ★ 811.3K |
| Earning Date | 03-26-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.92% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.55 | $867.86 |
| Revenue Next Year | $5.40 | N/A |
| P/E Ratio | $338.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $60.02 | $39.60 |
| 52 Week High | $81.89 | $105.69 |
Technical Indicators
Market Signals| Indicator | DOO | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 56.73 |
| Support Level | $62.57 | $76.63 |
| Resistance Level | $81.52 | $100.00 |
| Average True Range (ATR) | 2.46 | 4.71 |
| MACD | 0.65 | 0.12 |
| Stochastic Oscillator | 63.93 | 53.74 |
Price Performance
Historical Comparison DOO
PTGX
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.